The healthcare world involves new economics that are driving moves toward increased scale and lower margins.  Evolving regulatory policy creates a moving target that can present both challenges and opportunities.  Companies in the life sciences areas–such as pharmaceutical, medical device, and biotech–need assistance to adapt to systemic shifts, like changes in reimbursement systems, DNA-based personal medicine and efforts to contain costs.

Our Healthcare & Pharmaceuticals Group is adept at assessing and implementing strategic alternatives, reviewing business lines and operations, properly allocating costs, optimizing working capital and liquidity, improving vendor and supply chain terms and balance sheet restructurings.

Selected Engagements